Best Practices in Diagnostic Immunohistochemistry: Workup of Cutaneous Lymphoid Lesions in the Diagnosis of Primary Cutaneous Lymphoma, Archives of Pathology & Laboratory Medicine, vol.139, issue.3, pp.338-50, 2015. ,
DOI : 10.5858/arpa.2014-0018-CP
Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France, JAMA Dermatology, vol.150, issue.5, pp.535-576, 2014. ,
DOI : 10.1001/jamadermatol.2013.7452
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas, Blood, vol.103, issue.10, pp.3662-3670, 2004. ,
DOI : 10.1182/blood-2003-08-2726
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, vol.103, issue.1, pp.275-82, 2004. ,
DOI : 10.1182/blood-2003-05-1545
Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma, Modern Pathology, vol.19, issue.9, pp.1270-1276, 2006. ,
DOI : 10.1038/modpathol.3800650
Cutaneous lymphomas: an update. Part 2: Bcell lymphomas and related conditions. The American Journal of dermatopathology, pp.197-208, 2014. ,
Nuclear Factor-??B Pathway???Activating Gene Aberrancies in Primary Cutaneous Large B-Cell Lymphoma, Leg Type, Journal of Investigative Dermatology, vol.134, issue.1, pp.290-292, 2014. ,
DOI : 10.1038/jid.2013.265
Oncogenically active MYD88 mutations in human lymphoma, Nature, vol.206, issue.7332, pp.115-124, 2010. ,
DOI : 10.1038/nature09671
High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type, JAMA Dermatology, vol.150, issue.11, 2014. ,
DOI : 10.1001/jamadermatol.2014.821
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome, Clinical Cancer Research, vol.22, issue.11, 2016. ,
DOI : 10.1158/1078-0432.CCR-15-1525
Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO???EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers, Journal of Clinical Oncology, vol.25, issue.12, pp.1581-1588, 2007. ,
DOI : 10.1200/JCO.2006.09.6396
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas, Blood, vol.112, issue.5, pp.1600-1609, 2008. ,
DOI : 10.1182/blood-2008-04-152850
WHO-EORTC classification for cutaneous lymphomas, Blood, vol.105, issue.10, pp.3768-85, 2005. ,
DOI : 10.1182/blood-2004-09-3502
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma, Nature Medicine, vol.21, issue.8, pp.922-928, 2015. ,
DOI : 10.1200/JCO.2006.09.2403